Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era

Abstract

Peer reviewed

Susan M. Hiniker, Erqi L. Pollom, Michael S. Khodadoust, Margaret M. Kozak, Ranjana H. Advani and Richard T. Hoppe

Journal of clinical oncology, Vol.32(15_suppl), pp.8544-8544

05/20/2014

DOI: 10.1200/jco.2014.32.15_suppl.8544

View Online

Title: Subtitle: Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era
Creators: Susan M. Hiniker - Stanford University
Erqi L. Pollom - Stanford University
Michael S. Khodadoust - Stanford University
Margaret M. Kozak - Stanford University
Ranjana H. Advani - Stanford University
Richard T. Hoppe - Stanford University
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.32(15_suppl), pp.8544-8544
DOI: 10.1200/jco.2014.32.15_suppl.8544
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2014
Academic Unit: Radiation Oncology
Record Identifier: 9984315658302771

10 Record Views